Registration
 
All news
Top Stories
Editors' Picks
Crypto
Financial News
Currencies
Market Voices
Companies
Regulators
Central Banks
Artem Shendetskii
Artem Shendetskii

Halozyme Therapeutics expands portfolio with Elektrofi acquisition

Halozyme Therapeutics expands portfolio with Elektrofi acquisition
@halozymeinc: Halozyme acquires Elektrofi

Halozyme Therapeutics has successfully completed its acquisition of Elektrofi, broadening its drug delivery capabilities.

By incorporating Elektrofi's Hypercon ultra-high concentration technology, Halozyme aims to make treatments more seamless for patients. This strategic move is expected to enhance their portfolio by integrating innovative technology that precisely aligns with patient needs. The acquisition is seen as a significant step in advancing drug delivery solutions, positioning Halozyme as a prominent player in the healthcare technology sector.

Industry experts suggest that this acquisition may pave the way for more personalized and efficient treatment options, thereby potentially transforming patient care.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
  • By Pavlo Kot
  • 20 hours ago
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
Editors' Picks
Blockchain nation in crisis: How a power struggle split Liberland
  • By Pavlo Kot
  • Yesterday
Blockchain nation in crisis: How a power struggle split Liberland
Editors' Picks
Shifting priorities: Governments back mining as businesses turn to AI
  • By Eugene Komchuk
  • 19.06.2026
Shifting priorities: Governments back mining as businesses turn to AI
Editors' Picks
All Editors' Top Picks

Latest Halozyme News

Halozyme Therapeutics stock under bearish pressure with technicals pointing to likely short-term consolidation
  • By Ezequiel Gomes
  • 18.06.2026
Halozyme Therapeutics stock under bearish pressure with technicals pointing to likely short-term consolidation
Companies
#Halozyme
Record revenue and royalties fail to lift Halozyme Therapeutics stock amid sustained technical weakness
  • By Ezequiel Gomes
  • 29.03.2026
Record revenue and royalties fail to lift Halozyme Therapeutics stock amid sustained technical weakness
Companies
#Halozyme
All Halozyme News
  • Pavlo Kot
  • 20 hours ago
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
  • Pavlo Kot
  • Yesterday
Blockchain nation in crisis: How a power struggle split Liberland
  • Eugene Komchuk
  • 19.06.2026
Shifting priorities: Governments back mining as businesses turn to AI
  • Mikhail Vnuchkov
  • 18.06.2026
Intel's comeback: Apple, Trump and the AI bet
  • Oleg Tkachenko
  • 17.06.2026
Bitcoin price prediction based on RSI: Is BTC poised for a new rally?
  • Hanna Syniavska
  • 17 min ago
BTCUSD value shown in real versus nominal dollars, Alex Thorn notes
  • Jose Antonio Gastelum
  • 22 min ago
Gracy Chen: Onchain access changes experience of buying NVIDIA stock
  • Oleg Tkachenko
  • 36 min ago
Quinten Francois: Bear market bottom signals appear as stocks reach historic overvaluations
  • Yaroslav Dmytrenko
  • 37 min ago
Kevin Susanto: Binance regulatory review a key test for Europe's crypto path
  • Eugene Komchuk
  • 1 hour ago
Leveraged buyouts leading to bankruptcies under loose policy, Dave Collum warns
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.
Top News
  • Pavlo Kot
  • 20 hours ago
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
  • Pavlo Kot
  • Yesterday
Blockchain nation in crisis: How a power struggle split Liberland
Blockchain nation in crisis: How a power struggle split Liberland
  • Andrey Mastykin
  • 19.06.2026
Iran tightens rules for Hormuz ship transit
Iran tightens rules for Hormuz ship transit
  • Hanna Syniavska
  • 19.06.2026
U.S.-Iran talks postponed as truce outlook dims
U.S.-Iran talks postponed as truce outlook dims
  • Olga Shendetskaya
  • 19.06.2026
Oil gains after new U.S.-Iran talks are called off
Oil gains after new U.S.-Iran talks are called off
Live News
  • Anton Kharitonov
  • Now
Microsoft under pressure as technical picture remains weak
  • Anton Kharitonov
  • Now
Apple consolidates after AI rally as investors await new growth catalyst
  • Anton Kharitonov
  • Now
Bitcoin struggles for direction amid macroeconomic uncertainty
  • Anton Kharitonov
  • Now
WTI recovers after selloff as downside risks remain
  • Anton Kharitonov
  • Now
Natural gas maintains upward bias amid supply risks and seasonal demand
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR